UK steps up its role in fighting global AMR

With 10 million people a year projected to die from antibiotic resistant infections by 2050, it is important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue

picture of

Breaking News

New survey reveals pioneering medical treatments should be available on NHS

New and potentially life-saving medical treatments, such as proton beam therapy, bone marrow transplant and stem cell ...

Constellium expands R&D capabilities at Brunel University

The aim of the facility is to transition technology from the laboratory to its production facilities around the world

Cancer Research UK tests unique lung cancer vaccine

A first of its kind treatment vaccine has moved into a phase I clinical trial for patients with non-small cell lung ...

Miniaturised organ equivalents for drug testing

Dr Reyk Horland, VP Business Development of TissUse, speaks to Angharad Baldwin of Manufacturing Chemist about a ...

FlexFactory helps scale up production of TCR T-Cell immunotherapy drugs

GE Healthcare will provide Xiangxue Pharmaceutical with a FlexFactory for cell therapy to help scale up, digitise and ...

Worldwide prescription drug sales accelerate to $1.2 trillion by 2024

Orphan drugs are forecast to remain one of the fastest growth areas of the global pharmaceutical market

The nanozyme that uses light to kill bacteria

Scientists at the RMIT University in Australia have created a nanozyme with antimicrobial properties with huge ...

£50m Randox Centres of Excellence launched in Northern Ireland

A record £50 million investment, which will deliver cutting-edge technologies to diagnose conditions like cancer, ...

Solving tableting scale-up challenges

At this year's ACHEMA Congress, Natoli Engineering will premiere two new and innovative products that will help tablet ...

Global partnership to expand pharma biocatalysis uptake

Codexis, Inc. and Porton Pharma Solutions recently announced a strategic collaboration to deploy Codexis’ world-leading ...

Accelerating drug discovery

Angharad Baldwin of Manufacturing Chemist speaks to Dr Trevor Perrior, CSO of Domainex, about the development of a new ...

Patient centricity: a winning formula

Industry has taken a collective pause in an effort to re-evaluate and rethink longstanding approaches to drug ...

TxCell names Lonza as its CAR-Treg cellular product manufacturer

Master Service Agreement signed between Lonza Pharma & Biotech and TxCell for the manufacture of TxCell’s HLA-A2 CAR- ...

Catalent Biologics supports InterveXion on new treatment for methamphetamine users

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for ...